Tags

Type your tag names separated by a space and hit enter

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.
Autoimmunity. 2015; 48(8):542-51.A

Abstract

OBJECTIVE

Autoantibodies directed against the two principal antigens of the human exosome complex, PM75 and PM100, are present in systemic sclerosis (SSc) sera and have been associated with myositis and calcinosis. However, there is a paucity of data on the clinical correlates of these autoantibodies separately and in the absence of other SSc-specific antibodies. The aim of this study was to assess the clinical correlates of monospecific anti-PM75 and anti-PM100 in SSc.

METHODS

A tri-nation cohort of 1574 SSc subjects was formed, clinical variables were harmonized and sera were tested for anti-PM75 and anti-PM100 antibodies using a line immunoassay.

RESULTS

Forty-eight (3.0%) subjects had antibodies against PM75 and 18 (1.1%) against PM100. However, only 16 (1%) had monospecific anti-PM75 antibodies and 11 (0.7%) monospecific anti-PM100 antibodies (i.e. in isolation of each other and other SSc-specific antibodies). Monospecific profiles of each autoantibody included more calcinosis. An increased frequency of myositis was only seen in subjects positive for both anti-PM75 and anti-PM100 antibodies. Lung disease was only associated with anti-PM75 and subjects with anti-PM100 antibodies had better survival compared to other antibody subsets.

CONCLUSION

The prevalence of monospecific anti-PM75 and anti-PM100 antibodies in this large SSc cohort was low. Disease features associated with anti-PM/Scl antibodies may depend on particular and possibly multiple antigen specificities. However, due to the small samples, these results need to be interpreted with caution. International collaborations are key to understanding the clinical correlates of uncommon serological profiles in SSc.

Authors+Show Affiliations

a Department of Medicine , McGill University , Montréal , Quebec , Canada .a Department of Medicine , McGill University , Montréal , Quebec , Canada . b Division of Rheumatology , Jewish General Hospital , Montréal , Quebec , Canada . c Lady Davis Institute, Jewish General Hospital , Montréal , Quebec , Canada .d Rheumatology Unit, Royal Adelaide Hospital , Adelaide , Australia . e Discipline of Medicine, University of Adelaide , Bedford Park , Australia .f Department of Allergy and Immunology , Flinders Medical Centre , Bedford Park , Australia .g Department of Rheumatology , St. Vincent's Hospital Melbourne , Fitzroy , Victoria , Australia .g Department of Rheumatology , St. Vincent's Hospital Melbourne , Fitzroy , Victoria , Australia . h Department of Medicine , The University of Melbourne at St. Vincent's Hospital , Melbourne , Victoria , Australia .i Division of Rheumatology and Immunogenetics , University of Texas Health Science Centre at Houston , Houston , TX , USA , and.i Division of Rheumatology and Immunogenetics , University of Texas Health Science Centre at Houston , Houston , TX , USA , and.c Lady Davis Institute, Jewish General Hospital , Montréal , Quebec , Canada .c Lady Davis Institute, Jewish General Hospital , Montréal , Quebec , Canada .No affiliation info availableNo affiliation info availableNo affiliation info availablea Department of Medicine , McGill University , Montréal , Quebec , Canada . b Division of Rheumatology , Jewish General Hospital , Montréal , Quebec , Canada . c Lady Davis Institute, Jewish General Hospital , Montréal , Quebec , Canada .j Faculty of Medicine, University of Calgary , Calgary , Alberta , Canada.

Pub Type(s)

Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

Language

eng

PubMed ID

26334795

Citation

Wodkowski, Michael, et al. "Clinical Correlates of Monospecific anti-PM75 and anti-PM100 Antibodies in a Tri-nation Cohort of 1574 Systemic Sclerosis Subjects." Autoimmunity, vol. 48, no. 8, 2015, pp. 542-51.
Wodkowski M, Hudson M, Proudman S, et al. Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity. 2015;48(8):542-51.
Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., Assassi, S., Mayes, M. D., Tatibouet, S., Wang, M., Baron, M., & Fritzler, M. J. (2015). Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity, 48(8), 542-51. https://doi.org/10.3109/08916934.2015.1077231
Wodkowski M, et al. Clinical Correlates of Monospecific anti-PM75 and anti-PM100 Antibodies in a Tri-nation Cohort of 1574 Systemic Sclerosis Subjects. Autoimmunity. 2015;48(8):542-51. PubMed PMID: 26334795.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. AU - Wodkowski,Michael, AU - Hudson,Marie, AU - Proudman,Susanna, AU - Walker,Jennifer, AU - Stevens,Wendy, AU - Nikpour,Mandana, AU - Assassi,Shervin, AU - Mayes,Maureen D, AU - Tatibouet,Solène, AU - Wang,Mianbo, AU - ,, AU - ,, AU - ,, AU - Baron,Murray, AU - Fritzler,Marvin J, Y1 - 2015/08/31/ PY - 2015/9/4/entrez PY - 2015/9/4/pubmed PY - 2016/9/22/medline KW - Autoantibodies KW - anti-PM/Scl antibodies KW - autoimmunity KW - observational cohort KW - systemic sclerosis SP - 542 EP - 51 JF - Autoimmunity JO - Autoimmunity VL - 48 IS - 8 N2 - OBJECTIVE: Autoantibodies directed against the two principal antigens of the human exosome complex, PM75 and PM100, are present in systemic sclerosis (SSc) sera and have been associated with myositis and calcinosis. However, there is a paucity of data on the clinical correlates of these autoantibodies separately and in the absence of other SSc-specific antibodies. The aim of this study was to assess the clinical correlates of monospecific anti-PM75 and anti-PM100 in SSc. METHODS: A tri-nation cohort of 1574 SSc subjects was formed, clinical variables were harmonized and sera were tested for anti-PM75 and anti-PM100 antibodies using a line immunoassay. RESULTS: Forty-eight (3.0%) subjects had antibodies against PM75 and 18 (1.1%) against PM100. However, only 16 (1%) had monospecific anti-PM75 antibodies and 11 (0.7%) monospecific anti-PM100 antibodies (i.e. in isolation of each other and other SSc-specific antibodies). Monospecific profiles of each autoantibody included more calcinosis. An increased frequency of myositis was only seen in subjects positive for both anti-PM75 and anti-PM100 antibodies. Lung disease was only associated with anti-PM75 and subjects with anti-PM100 antibodies had better survival compared to other antibody subsets. CONCLUSION: The prevalence of monospecific anti-PM75 and anti-PM100 antibodies in this large SSc cohort was low. Disease features associated with anti-PM/Scl antibodies may depend on particular and possibly multiple antigen specificities. However, due to the small samples, these results need to be interpreted with caution. International collaborations are key to understanding the clinical correlates of uncommon serological profiles in SSc. SN - 1607-842X UR - https://www.unboundmedicine.com/medline/citation/26334795/Clinical_correlates_of_monospecific_anti_PM75_and_anti_PM100_antibodies_in_a_tri_nation_cohort_of_1574_systemic_sclerosis_subjects_ L2 - https://www.tandfonline.com/doi/full/10.3109/08916934.2015.1077231 DB - PRIME DP - Unbound Medicine ER -